Literature DB >> 8063746

Expression of catalytically inactive Syp phosphatase in 3T3 cells blocks stimulation of mitogen-activated protein kinase by insulin.

K L Milarski1, A R Saltiel.   

Abstract

To explore the role of the protein tyrosine phosphatase Syp in insulin signaling, a catalytically inert mutant Syp protein was expressed under an inducible promoter in cells transfected with the human insulin receptor. Expression of the mutant phosphatase significantly reduced the stimulation of mitogenesis by insulin, indicating that the mutation produced a dominant negative phenotype. Tyrosine phosphorylation of both the insulin receptor and its major substrates, Shc and insulin receptor substrate-1, were unaffected by the mutant phosphatase. However, both the insulin-dependent tyrosine phosphorylation and activation of mitogen-activated protein kinase were markedly attenuated. Expression of the mutant phosphatase allowed the detection of a 120-kDa protein phosphorylated in response to insulin that associated with the src homology (SH) 2 domains of the phosphatase, suggesting a possible regulatory role for this protein. These results indicate that the activity of Syp plays a critical part in the mitogenic actions of insulin.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8063746

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  71 in total

1.  Regulation of neuregulin-mediated acetylcholine receptor synthesis by protein tyrosine phosphatase SHP2.

Authors:  M Tanowitz; J Si; D H Yu; G S Feng; L Mei
Journal:  J Neurosci       Date:  1999-11-01       Impact factor: 6.167

2.  The tyrosine phosphatase SHP-2 is required for sustained activation of extracellular signal-regulated kinase and epithelial morphogenesis downstream from the met receptor tyrosine kinase.

Authors:  C R Maroun; M A Naujokas; M Holgado-Madruga; A J Wong; M Park
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

3.  SHP-2 mediates target-regulated axonal termination and NGF-dependent neurite growth in sympathetic neurons.

Authors:  Bo Chen; Latanya Hammonds-Odie; Jeanette Perron; Brian A Masters; John L Bixby
Journal:  Dev Biol       Date:  2002-12-15       Impact factor: 3.582

4.  SHP-2 positively regulates myogenesis by coupling to the Rho GTPase signaling pathway.

Authors:  Maria I Kontaridis; Seda Eminaga; Mara Fornaro; Christina Ivins Zito; Raffaella Sordella; Jeffrey Settleman; Anton M Bennett
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

Review 5.  Targeting protein tyrosine phosphatases for anticancer drug discovery.

Authors:  Latanya M Scott; Harshani R Lawrence; Saïd M Sebti; Nicholas J Lawrence; Jie Wu
Journal:  Curr Pharm Des       Date:  2010-06       Impact factor: 3.116

6.  Kinase activation through dimerization by human SH2-B.

Authors:  Masahiro Nishi; Eric D Werner; Byung-Chul Oh; J Daniel Frantz; Sirano Dhe-Paganon; Lone Hansen; Jongsoon Lee; Steven E Shoelson
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

Review 7.  The Src homology 2 domain tyrosine phosphatases SHP-1 and SHP-2: diversified control of cell growth, inflammation, and injury.

Authors:  Z Z Chong; K Maiese
Journal:  Histol Histopathol       Date:  2007-11       Impact factor: 2.303

8.  The association between integrin-associated protein and SHPS-1 regulates insulin-like growth factor-I receptor signaling in vascular smooth muscle cells.

Authors:  Laura A Maile; Jane Badley-Clarke; David R Clemmons
Journal:  Mol Biol Cell       Date:  2003-05-29       Impact factor: 4.138

Review 9.  Recent advances in the understanding of interleukin-2 signal transduction.

Authors:  F Gesbert; M Delespine-Carmagnat; J Bertoglio
Journal:  J Clin Immunol       Date:  1998-09       Impact factor: 8.317

10.  Stimulation of protein synthesis, eukaryotic translation initiation factor 4E phosphorylation, and PHAS-I phosphorylation by insulin requires insulin receptor substrate 1 and phosphatidylinositol 3-kinase.

Authors:  R Mèndez; M G Myers; M F White; R E Rhoads
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.